These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32556806)

  • 61. NMR screening and hit validation in fragment based drug discovery.
    Campos-Olivas R
    Curr Top Med Chem; 2011; 11(1):43-67. PubMed ID: 20809889
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rapid acquisition of 1H and 19F NMR experiments for direct and competition ligand-based screening.
    Dalvit C; Gossert AD; Coutant J; Piotto M
    Magn Reson Chem; 2011 Apr; 49(4):199-202. PubMed ID: 21387401
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ligand-Based Competition Binding by Real-Time
    Luchinat E; Barbieri L; Davis B; Brough PA; Pennestri M; Banci L
    J Med Chem; 2024 Jan; 67(2):1115-1126. PubMed ID: 38215028
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development of
    Furihata K; Tashiro M
    Anal Sci; 2022 May; 38(5):825-829. PubMed ID: 35318618
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protocol to perform fragment screening using NMR spectroscopy.
    Huang Q; Kang C
    STAR Protoc; 2024 Sep; 5(3):103278. PubMed ID: 39178109
    [TBL] [Abstract][Full Text] [Related]  

  • 66.
    Lu M; Sarkar S; Wang M; Kraus J; Fritz M; Quinn CM; Bai S; Holmes ST; Dybowski C; Yap GPA; Struppe J; Sergeyev IV; Maas W; Gronenborn AM; Polenova T
    J Phys Chem B; 2018 Jun; 122(23):6148-6155. PubMed ID: 29756776
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fluorine labelling for in situ
    Cockburn KT; Sykes BD
    J Biomol NMR; 2024 Jun; 78(2):119-124. PubMed ID: 38407676
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mass spectrometry for fragment screening.
    Chan DS; Whitehouse AJ; Coyne AG; Abell C
    Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Protein-Templated Fragment Ligations-From Molecular Recognition to Drug Discovery.
    Jaegle M; Wong EL; Tauber C; Nawrotzky E; Arkona C; Rademann J
    Angew Chem Int Ed Engl; 2017 Jun; 56(26):7358-7378. PubMed ID: 28117936
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Feasibility of trifluoromethyl TROSY NMR at high magnetic fields.
    Klein BA; Sykes BD
    J Biomol NMR; 2019 Nov; 73(10-11):519-523. PubMed ID: 31267350
    [TBL] [Abstract][Full Text] [Related]  

  • 71. New probes of ligand flexibility in drug design: transferred (13)C CSA-dipolar cross-correlated relaxation at natural abundance.
    Peng JW
    J Am Chem Soc; 2003 Sep; 125(36):11116-30. PubMed ID: 12952494
    [TBL] [Abstract][Full Text] [Related]  

  • 72. NMR-Fragment Based Virtual Screening: A Brief Overview.
    Singh M; Tam B; Akabayov B
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29370102
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prediction of fluorine chemical shifts in proteins.
    Gregory DH; Gerig JT
    Biopolymers; 1991 Jun; 31(7):845-58. PubMed ID: 1912343
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Weak Intermolecular Hydrogen Bonds with Fluorine: Detection and Implications for Enzymatic/Chemical Reactions, Chemical Properties, and Ligand/Protein Fluorine NMR Screening.
    Dalvit C; Vulpetti A
    Chemistry; 2016 May; 22(22):7592-601. PubMed ID: 27112430
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fluorine NMR functional screening: from purified enzymes to human intact living cells.
    Dalvit C; Veronesi M; Vulpetti A
    J Biomol NMR; 2020 Nov; 74(10-11):613-631. PubMed ID: 32347447
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Solution NMR Spectroscopy in Target-Based Drug Discovery.
    Li Y; Kang C
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28832542
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Improved estimation of CSA-dipolar coupling cross-correlation rates from laboratory-frame relaxation experiments.
    Ghose R; Prestegard JH
    J Magn Reson; 1998 Oct; 134(2):308-14. PubMed ID: 9867423
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Applications of Dissolution-DNP for NMR Screening.
    Kim Y; Hilty C
    Methods Enzymol; 2019; 615():501-526. PubMed ID: 30638540
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Measurement of cross correlation between dipolar coupling and chemical shift anisotropy in the spin relaxation of 13C, 15N-labeled proteins.
    Ghose R; Huang K; Prestegard JH
    J Magn Reson; 1998 Dec; 135(2):487-99. PubMed ID: 9878476
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Target immobilization and NMR screening of fragments in early drug discovery.
    Siegal G; Hollander JG
    Curr Top Med Chem; 2009; 9(18):1736-45. PubMed ID: 19929836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.